MoonLake Immunotherapeutics (MLTX)
39.74
-1.12
(-2.74%)
USD |
NASDAQ |
May 17, 16:00
39.74
0.00 (0.00%)
After-Hours: 20:00
MoonLake Immunotherapeutics Stock Buybacks (Quarterly): -52.54M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -52.54M |
December 31, 2023 | -31.17M |
September 30, 2023 | 0.00 |
June 30, 2023 | -451.29M |
Date | Value |
---|---|
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-451.29M
Minimum
Jun 2023
--
Maximum
Jun 2022
-66.87M
Average
--
Median
Jun 2022
Stock Buybacks (Quarterly) Benchmarks
Qiagen NV | 0.00 |
LENZ Therapeutics Inc | -53.39M |
AC Immune SA | -0.0023M |
CRISPR Therapeutics AG | -280.74M |
Addex Therapeutics Ltd | -1.304M |